BACKGROUND: The aim of the study was to analyze speech outcome for patients with advanced oral/oropharyngeal cancer treated with reconstructive surgery and adjuvant radiotherapy. METHODS: Speech tests (communicative suitability, intelligibility, articulation, nasality, and consonant errors) were performed in a control group and in patients before treatment (n = 76), and 6 months (n = 51) and 12 months (n = 42) after treatment. RESULTS: Speech tests were significantly worse for patients before and after treatment compared with the controls. Speech did not improve between 6 and 12 months. After treatment, patients with T3-4 tumors showed a significantly worse score for communicative suitability, intelligibility, and articulation than patients with T2 tumors. No significant differences were found for subsites after treatment, although patients with mobile tongue tumors showed the best results. CONCLUSION: Speech difficulties are significant, and with the knowledge of this study better counseling and vigilance as to speech difficulties may be possible in patients undergoing treatment for oral/oropharyngeal cancer. (c) 2005 Wiley Periodicals, Inc.
BACKGROUND: The aim of the study was to analyze speech outcome for patients with advanced oral/oropharyngeal cancer treated with reconstructive surgery and adjuvant radiotherapy. METHODS: Speech tests (communicative suitability, intelligibility, articulation, nasality, and consonant errors) were performed in a control group and in patients before treatment (n = 76), and 6 months (n = 51) and 12 months (n = 42) after treatment. RESULTS: Speech tests were significantly worse for patients before and after treatment compared with the controls. Speech did not improve between 6 and 12 months. After treatment, patients with T3-4 tumors showed a significantly worse score for communicative suitability, intelligibility, and articulation than patients with T2 tumors. No significant differences were found for subsites after treatment, although patients with mobile tongue tumors showed the best results. CONCLUSION: Speech difficulties are significant, and with the knowledge of this study better counseling and vigilance as to speech difficulties may be possible in patients undergoing treatment for oral/oropharyngeal cancer. (c) 2005 Wiley Periodicals, Inc.
Authors: Dana L Grimm; Maureen Stone; Jonghye Woo; Junghoon Lee; Jun-Hyuk Hwang; Gary E Bedrosian; Jerry L Prince Journal: J Speech Lang Hear Res Date: 2017-12-20 Impact factor: 2.297
Authors: Raghav C Dwivedi; Edward J Chisholm; Afroze S Khan; Nicholas J Harris; Shree A Bhide; Suzanne St Rose; Cyrus J Kerawala; Peter M Clarke; Christopher M Nutting; Peter H Rhys-Evans; Kevin J Harrington; Rehan Kazi Journal: Eur Arch Otorhinolaryngol Date: 2011-09-10 Impact factor: 2.503
Authors: Raghav C Dwivedi; Suzanne St Rose; Edward J Chisholm; Christos Georgalas; Brian Bisase; Furrat Amen; Cyrus J Kerawala; Peter M Clarke; Christopher M Nutting; Peter H Rhys-Evans; Kevin J Harrington; Rehan Kazi Journal: Dysphagia Date: 2012-02-21 Impact factor: 3.438
Authors: Remco de Bree; Alessandra Rinaldo; Eric M Genden; Carlos Suárez; Juan Pablo Rodrigo; Johannes J Fagan; Luiz P Kowalski; Alfio Ferlito; C René Leemans Journal: Eur Arch Otorhinolaryngol Date: 2007-08-08 Impact factor: 2.503
Authors: Tanya L Eadie; Holly Durr; Cara Sauder; Kathleen Nagle; Mara Kapsner-Smith; Kristie A Spencer Journal: Am J Speech Lang Pathol Date: 2021-02-25 Impact factor: 2.408
Authors: Christien A de Witt; Remco de Bree; Irma M Verdonck-de Leeuw; Jasper J Quak; C René Leemans Journal: Eur Arch Otorhinolaryngol Date: 2007-02-24 Impact factor: 2.503
Authors: Johannes N Lodders; Satyesh Parmar; Niki L M Stienen; Timothy J Martin; K Hakki Karagozoglu; Martijn W Heymans; Baljeet Nandra; Tymour Forouzanfar Journal: Med Oral Patol Oral Cir Bucal Date: 2015-11-01